Company Name: CS MEDICA A/S ISIN: DK0061668225   Reason for the research: Initiation Recommendation: Buy from: 04.11.2024 Target price: EUR 2.30 Target price on sight of: 12 months Last rating change: Analyst: Christian Sandherr Revolutionizing alternative medicine; Initiate with BUY CS MEDICA, a Danish Med-Tech company founded [ … ]

The shares of CS MEDICA A/S (ISIN DK0061668225) have been listed on the Frankfurt Stock Exchange since March 2, 2023. The company, a MedTech pioneer in the development of medical devices that benefit from bioactive CBD, has mandated the private bank Hauck Aufhäuser Lampe to include the company's shares in Deutsche Börse AG's trading venue XETRA and [ … ]

  Strategic Milestone Achieved as CANNORDIC, a CS MEDICA Subsidiary, Navigates Regulatory Challenges to Expand Global Footprint   CS MEDICA Group, a leader in innovative substance-based medical devices containing bioactive CBD, is proud to announce the successful completion of the product registration process for its entire CANNASEN® portfolio o [ … ]

  Strategic Milestone Achieved as CANNORDIC, a CS MEDICA Subsidiary, Navigates Regulatory Challenges to Expand Global Footprint   CS MEDICA Group, a leader in innovative substance-based medical devices containing bioactive CBD, is proud to announce the successful completion of the product registration process for its entire CANNASEN® portfolio o [ … ]

CS MEDICA A/S, a pioneering MedTech company specializing in innovative substance-based medical devices containing bioactive CBD, today announced its plans to spin off and list its subsidiary CANNORDIC A/S on the German Stock Market (Intention to Float).   CS MEDICA ("CS MEDICA" or "The Company") aims to elevate the value of CS MEDICA's shares, ta [ … ]